Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Barrow

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|October 3, 1998
Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophagesE L Barrow, G A Winchester, J K Staas, et al.
Journal of Biomolecular Screening|June 2, 2012
High-throughput screening of a diversity collection using biodefense category A and B priority pathogensEsther W Barrow, Patricia A Clinkenbeard, Rebecca A Duncan-Decocq, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazidD C Quenelle, G A Winchester, J K Staas, et al.
Infection and Immunity|January 1, 1995
Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8W W Barrow, T L Davis, E L Wright, et al.
Research in Microbiology|January 1, 1996
Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosisN Rastogi, K S Goh, S Z Van Ginkel, et al.
Journal of Molecular Recognition : JMR|March 22, 2012
Classifying compound mechanism of action for linking whole cell phenotypes to molecular targetsChristina R Bourne, Nancy Wakeham, Richard A Bunce, et al.
Infection and Immunity|December 1, 1993
Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium aviumW W Barrow, J P de Sousa, T L Davis, et al.
Biochemistry|February 6, 2014
The structure and competitive substrate inhibition of dihydrofolate reductase from Enterococcus faecalis reveal restrictions to cofactor dockingChristina R Bourne, Nancy Wakeham, Nicole Webb, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosisZe-Qi Xu, William W Barrow, William J Suling, et al.
The British Journal of Dermatology|September 24, 2018
Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapyA L Marano, J M Clarke, M A Morse, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|October 3, 1998
Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophagesE L Barrow, G A Winchester, J K Staas, et al.
Journal of Biomolecular Screening|June 2, 2012
High-throughput screening of a diversity collection using biodefense category A and B priority pathogensEsther W Barrow, Patricia A Clinkenbeard, Rebecca A Duncan-Decocq, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazidD C Quenelle, G A Winchester, J K Staas, et al.
Infection and Immunity|January 1, 1995
Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8W W Barrow, T L Davis, E L Wright, et al.
Research in Microbiology|January 1, 1996
Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosisN Rastogi, K S Goh, S Z Van Ginkel, et al.
Journal of Molecular Recognition : JMR|March 22, 2012
Classifying compound mechanism of action for linking whole cell phenotypes to molecular targetsChristina R Bourne, Nancy Wakeham, Richard A Bunce, et al.
Infection and Immunity|December 1, 1993
Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium aviumW W Barrow, J P de Sousa, T L Davis, et al.
Biochemistry|February 6, 2014
The structure and competitive substrate inhibition of dihydrofolate reductase from Enterococcus faecalis reveal restrictions to cofactor dockingChristina R Bourne, Nancy Wakeham, Nicole Webb, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosisZe-Qi Xu, William W Barrow, William J Suling, et al.
The British Journal of Dermatology|September 24, 2018
Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapyA L Marano, J M Clarke, M A Morse, et al.
Pageof 9